Introduction
Breast cancer affects more than 1 million women worldwide. It is the most common type of cancer and the second leading cause of cancer related death among women
(1)
. The estimated incidence in 2018 was 2.088 million of new cases in the world (2) . Breast cancer was the most common cancer among women and the third leading cause of cancer related death in Egypt . In 2012; 18,660 new cases were estimated in Egypt and out of them the mortality rates was estimated at 7,161
(4)
. Recurrence of breast cancer is a major clinical manifestation and represents the principal cause of breast cancerrelated deaths
(5)
.Loco-regional recurrence (LRR, ipsilateral breast or axillary lymph nodes)may occur in 5-27% of patients (6) . Early detection and treatment of isolated LRR before symptomatic onset may have a beneficial effect on the prognosis, by improving local treatment feasibility rate and by avoiding the situation of uncontrollable loco-regional disease . Conventional imaging methods which reflect mainly the morphological changes are often inconclusive in differentiating local pathology from post therapeutic changes. . PET/CT is particularly useful in patients who are suspected to have or who are exhibiting a recurrence on physical examination or conventional imaging methods (11) . Sensitivity of PET/CT for detecting LRR or metastasis among patients with breast cancer is approximately 97%, with a diagnostic accuracy of 95% in one study, supporting the efficacy of PET/CT for patients diagnosed or suspected of having recurrent breast cancer (12) . However, there is a lack of evidence demonstrating the efficacy and cost effectiveness of this modality, along with the hazards of radiation exposure and the absence of specific clinical indications (13) . This study was designed to evaluate the effectiveness of 18 FDG PET/CT study was done using a dedicated PET/CT scanner (GE, PET/CT Discovery). This camera integrates a PET scanner with a dualsection helical CT scanner (40 slice Emotion) and allows the acquisition of co-registered CT and PET images in one session. Scanning started 60-90 min after tracer injection of 370-555 MBq of 18 F-FDG in the forearm. Intravenous contrast agent was administered in most patients. Pretest 6 hours fasting period was required (only water was allowed) and blood glucose level was assessed to insure proper blood glucose level (<200mg/dl). Each patient was imaged from the skull to mid-thigh in the supine position with arms elevated, and CT scanning was started at the level of the Cervico-thoracic region with the following parameters: 400 mAs; 120 kV; slice thickness, 3 mm; pitch, 1.5. The CT scans were acquired during normal respiration reached caudally to the mid thighs. PET was performed immediately after acquisition of the CT images (5-7 bed positions; acquisition time, 2 -3 min/bed position). The CT-data were used for attenuation correction, and images were reconstructed as 5-mm slices applying a standard iterative algorithm (ordered-subset expectation maximization).
II.
B) Image reconstruction:Maximum intensity whole body projection (MIP), sagittal, coronal and axial slices were reconstructed using dedicated PET software system.
Images were interpreted at a workstation equipped with fusion software (advantage Window AW version 5, GE) that provides multi-planar reformatted images and enables display of the PET images, CT images, and fused PET/CT images was interpreted by 2 experienced nuclear medicine physicians. Graphs were produced by using Excel. P value < 0.05 was considered statistically significant.
Results
The mean age ± SD of the patients was 58.47±9.1 years (Range= 40-77 years).The vast majority of the patients had either CBS or MRM (18/45; 40% for each). Radical mastectomy was done in 8 cases (17.8%). Around half of the cases (22 cases, 49%) had isolated left sided tumor, with 16 cases (35.5%) had isolated left sided tumor.
CT finding of the study populations:
The most commonly abnormality found was lymph node affection in one third of cases (15 cases, 33.3%). The findings of CT in the study populations are shown in table 1.
FDG PET/CT findings:
The most commonly abnormality found was lymph node affection in more than third of cases (16/45, 35.6%). The findings of PET/CT in the study populations are shown in table 2. 
Comparison between CT and PET/CT performance in detecting LRR:
By comparing the CT, and PET for signs of recurrence; it was found that PET was the most accurate (81.07%), with the highest sensitivity (88.46%), and specificity (73.68%) ( Table 3) . Comparison of CT and PET performance in detecting breast cancer distant metastasis: Performance of CT in comparison to PET results is shown in Table 4 . 
Results of histopathology:
Out of the 45 patients; biopsy was taken from only 14 patients. Out of them; 10 cases (10/14; 71.4%) were positive for recurrence. Out of the 10 positive cases; 8 cases (80%) were positive recurrence by PET/CT and the other 2 cases (20%) were suspicious of recurrence by PET/CT. All the 4 negative cases were also negative for recurrence by PET/CT.
Discussion
Recurrence of breast cancer is a major clinical manifestation and represents the principal cause of breast cancerrelated deaths
(5)
.PET/CT may be used for early detection of LRR of breast cancer (11) . In the current study; FDG-PET/CT was more accurate than CT in diagnosing LRR of breast cancer (Overall accuracy= 81.07% versus 71.96% respectively). This is in agreement with previous reports of Radan et al. (14) 
Referrences
Also; for the calculation of sensitivity and specificity, a person-based approach was used instead of one that was lesion based. This procedure reflects that treatment decisions are generally made based on the presence of recurrent or metastatic disease, rather than on the number of lesions involved. Consequently, it is clinically more relevant to consider the patientbased data rather than the lesion-based analyses. 
